What is Alecensa?
Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase and is used to treat non-small-cell lung cancer. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group
Alecensa (alectinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Alecensa is used to treat non-small cell lung cancer that has spread to other parts of the body. Alecensa is usually given after another medicine has been tried without success.
Alecensa was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, tumors responded to this medicine. However, further studies are needed to determine if this medicine can lengthen survival time.
Alecensa side effects
Get emergency medical help if you have signs of an allergic reaction to Alecensa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
a very slow heart rate;
a light-headed feeling, like you, might pass out;
unexplained muscle pain, tenderness, or weakness;
sudden chest pain or discomfort, wheezing, dry cough or a cough with mucus, feeling short of breath; or
liver problems - nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Do not use alectinib if you are pregnant. It could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 1 week after your last dose.
If you are a man, use effective birth control if your sexual partner is able to get pregnant. An unborn baby can be harmed if a man fathers the child while he is taking alectinib. Keep using birth control for at least 3 months after your treatment ends.
Storage and stability:
Do not store above 30.C (86.F). Store in the original container to protect from light and moisture.
Alecensa alectinib 150 mg
- Product Code: alectinib
- Prescription Required